Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00673309 · ClinicalTrials.gov registry record · Phase 2
Assessment of Mechanisms of Improved Wound Healing
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 2
- Development phase
- 644
- Enrollment target
NCT00673309: Completed Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT00673309 is a Phase 2 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 644 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (384% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00673309, a Phase 2 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 644 participants
- Enrollment target
Study Summary
The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.
Primary Outcome
At the request of the study site, this study has been closed. Access to study-related data is unavailable, and the PI is no longer at the institution. Hence, we are unable to submit the results data. Although peer-reviewed articles have been located that reference NCT00673309, it is not clear and verifiable (without access to the actual study-related data) what the results for the study outcomes are.
Interventions
- DRUG Propranolol
- DRUG Growth Hormone
- PROCEDURE Stable Isotope Infusion study
- DRUG Insulin High Dose
- DRUG oxandrolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 644 participants |
| Start Date | 2000-07 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
What the finished NCT00673309 record still lists
NCT00673309 is an interventional study that assigns participants to a tested intervention. The registered 644 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (384% higher).
The record links to 0 conditions, and to 5 interventions - of which Propranolol is the first listed.
NCT00673309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00673309 about?
NCT00673309 is a clinical study titled "Assessment of Mechanisms of Improved Wound Healing". The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.
What is the current status of trial NCT00673309?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 644 participants. The study started on 2000-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00673309?
The interventions under investigation include: Propranolol (DRUG), Growth Hormone (DRUG), Stable Isotope Infusion study (PROCEDURE), Insulin High Dose (DRUG), oxandrolone (DRUG).
Who is sponsoring clinical trial NCT00673309?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00673309's enrollment target sits among peer trials
644 50th of 2000 higher than 1,951 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- NCT04863222 · 646 participants · Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia